Page 24 - JCTR-9-5

326 Mahmood et al. | Journal of Clinical and Translational Research 2023; 9(5): 322-326
2007;10:12-29. Potential Curative Therapy for Early Hepatocellular
[9] Riaz A, Gates VL, Atassi B, Lewandowski RJ, Carcinoma. Radiology 2018;287:1050-8.
Mulcahy MF, Ryu RK, et al. Radiation Segmentectomy: [12] Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R,
A Novel Approach to Increase Safety and Efficacy Broglio KR, et al. Recurrence and Outcomes Following
of Radioembolization. Int J Radiat Oncol Biol Phys Hepatic Resection, Radiofrequency Ablation, and
2011;79:163-71. Combined Resection/Ablation for Colorectal Liver
[10] Padia SA, Kwan SW, Roudsari B, Monsky WL, Coveler A, Metastases. Ann Surg 2004;239:818-25.
Harris WP. Superselective Yttrium-90 Radioembolization [13] Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B,
for Hepatocellular Carcinoma Yields High Response Meyerhardt JA, et al. Effect of First-Line Chemotherapy
Rates with Minimal Toxicity. J Vasc Interv Radiol Combined with Cetuximab or Bevacizumab on Overall
2014;25:1067-73. Survival in Patients with KRAS Wild-Type Advanced
[11] Lewandowski RJ, Gabr A, Abouchaleh N, Ali R, or Metastatic Colorectal Cancer: A Randomized Clinical
Al Asadi A, Mora RA, et al. Radiation Segmentectomy: Trial. JAMA 2017;317:2392-401.

Publisher’s note
AccScience Publishing remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
DOI: http://dx.doi.org/10.18053/jctres.09.202305.23-00066